Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Ben Fredj

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Therapie|April 16, 2025
Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel diseaseZohra Chadli, Ibtissem Hannachi, Nadia Ben Fredj, et al.
Biochemical Genetics|May 12, 2025
Genetic and Non-genetic Correlates of Imatinib Pharmacokinetics and Side Effects of Imatinib in Palestinian Patients with Chronic Myeloid LeukemiaDeema Hilmi Adawi, Ahmad Al-Barghouthi, Nadia Ben Fredj, et al.
Contact Dermatitis|January 22, 2019
Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicamHaifa Ben Romdhane, Helmi Ammar, Najeh Ben Fadhel, et al.
Acta Parasitologica|October 28, 2018
Meglumine antimoniate-induced DRESS: original case with a positive skin testAmel Chaabane, Haifa Ben Romdhane, Hajer Ben Brahim, et al.
British Journal of Clinical Pharmacology|November 12, 2020
Beta-lactam hypersensitivity in children: Frequency and risk factorsHaifa Ben Romdhane, Nadia Ben Fredj, Najah Ben Fadhel, et al.
Therapeutic Drug Monitoring|January 29, 2015
Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation TimeKarim Aouam, Zohra Chadli, Mouna Hammouda, et al.
Journal of Clinical Pharmacology|January 5, 2021
Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With TuberculosisMohammed Alshaikheid, Haifa Ben Romdhane, Nadia Ben Fredj, et al.
Journal of Neuroimmunology|April 17, 2014
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibilityNadia Ben Fredj, Roberta Rizzo, Daria Bortolotti, et al.
Contact Dermatitis|February 19, 2026
Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20-Year Single-Centre ExperienceZohra Chadli, Khadija Mansour, Ghada Jaouahdou, et al.
Journal of Neurovirology|November 8, 2011
Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donorsNadia Ben Fredj, Antonella Rotola, Faten Nefzi, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Therapie|April 16, 2025
Usefulness of thiopurines therapeutic drug monitoring in patients with inflammatory bowel diseaseZohra Chadli, Ibtissem Hannachi, Nadia Ben Fredj, et al.
Biochemical Genetics|May 12, 2025
Genetic and Non-genetic Correlates of Imatinib Pharmacokinetics and Side Effects of Imatinib in Palestinian Patients with Chronic Myeloid LeukemiaDeema Hilmi Adawi, Ahmad Al-Barghouthi, Nadia Ben Fredj, et al.
Contact Dermatitis|January 22, 2019
Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicamHaifa Ben Romdhane, Helmi Ammar, Najeh Ben Fadhel, et al.
Acta Parasitologica|October 28, 2018
Meglumine antimoniate-induced DRESS: original case with a positive skin testAmel Chaabane, Haifa Ben Romdhane, Hajer Ben Brahim, et al.
British Journal of Clinical Pharmacology|November 12, 2020
Beta-lactam hypersensitivity in children: Frequency and risk factorsHaifa Ben Romdhane, Nadia Ben Fredj, Najah Ben Fadhel, et al.
Therapeutic Drug Monitoring|January 29, 2015
Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation TimeKarim Aouam, Zohra Chadli, Mouna Hammouda, et al.
Journal of Clinical Pharmacology|January 5, 2021
Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With TuberculosisMohammed Alshaikheid, Haifa Ben Romdhane, Nadia Ben Fredj, et al.
Journal of Neuroimmunology|April 17, 2014
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibilityNadia Ben Fredj, Roberta Rizzo, Daria Bortolotti, et al.
Contact Dermatitis|February 19, 2026
Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20-Year Single-Centre ExperienceZohra Chadli, Khadija Mansour, Ghada Jaouahdou, et al.
Journal of Neurovirology|November 8, 2011
Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donorsNadia Ben Fredj, Antonella Rotola, Faten Nefzi, et al.
Pageof 6